Lizhu Pharmaceutical (01513): Health Yuan plans to transfer 49% of Mao Children's shares to Hearty Mao Children

According to Zhitong Finance App, Lizhu Pharmaceutical (01513) announced that on December 30, 2025, the company signed a capital increase subscription and share transfer agreement with Health Yuan (the company's controlling shareholder), Xinyou Mao, and Mao Dai. Xinyou Mao agreed to pledge a capital increase of RMB 15 million to Mao Kids in cash. At the same time, Health Yuan agreed to transfer 49% of Mao's shares to Xinyao. After the transaction is completed, Xinyou Mao Kids will hold 52.56% of Mao Kids's shares, the Company's shares will be diluted from 51.00% to 47.44%, Health Yuan will no longer hold Mao Kids shares, and Mao Kids will no longer be included in the Company's consolidated statements.

The company's strategy focuses on pharmaceutical R&D, production and sales, and is optimistic about the development potential of Mao's pet medicine industry. This transaction is an important step for the company to focus on its main business, optimize asset structure, and improve governance efficiency. It not only helps the company concentrate resources to promote its core business, but also sustainably share Mao's long-term growth potential.

After the transaction is completed, the company will invest more energy and resources in technological innovation and market expansion in the pharmaceutical sector to further consolidate and enhance the company's profitability, which is in line with the company's long-term development strategy and the overall interests of all shareholders.